<DOC>
	<DOCNO>NCT00420342</DOCNO>
	<brief_summary>The main purpose study compare effect treatment two different formulation AngeliqÂ® Prempro blood pressure post-menopausal woman prehypertension .</brief_summary>
	<brief_title>Effects Angeliq Prempro Blood Pressure Sodium Sensitivity Postmenopausal Women With Prehypertension</brief_title>
	<detailed_description>This study previously post Berlex , Inc. Berlex , Inc. rename Bayer HealthCare Pharmaceuticals , Inc.Bayer HealthCare Pharmaceuticals , Inc. sponsor trial .</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Prehypertension</mesh_term>
	<mesh_term>Estrogens , Conjugated ( USP )</mesh_term>
	<mesh_term>Estradiol</mesh_term>
	<mesh_term>Polyestradiol phosphate</mesh_term>
	<mesh_term>Ethinyl Estradiol</mesh_term>
	<mesh_term>Medroxyprogesterone</mesh_term>
	<mesh_term>Medroxyprogesterone Acetate</mesh_term>
	<mesh_term>Estradiol 3-benzoate</mesh_term>
	<mesh_term>Estradiol 17 beta-cypionate</mesh_term>
	<mesh_term>Estradiol valerate</mesh_term>
	<mesh_term>Drospirenone ethinyl estradiol combination</mesh_term>
	<mesh_term>Drospirenone</mesh_term>
	<criteria>Postmenopausal woman 45 65 year old prehypertension Hormone therapy ( estrogen/progestin )</criteria>
	<gender>Female</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>Pre-Hypertension Postmenopausal Women</keyword>
</DOC>